BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 22536780)

  • 1. Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances.
    Galuppo P; Bauersachs J
    Eur J Clin Invest; 2012 Oct; 42(10):1112-20. PubMed ID: 22536780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone, mineralocorticoid receptor, and heart failure.
    Messaoudi S; Azibani F; Delcayre C; Jaisser F
    Mol Cell Endocrinol; 2012 Mar; 350(2):266-72. PubMed ID: 21784127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptor and cardiac arrhythmia.
    Gravez B; Tarjus A; Jaisser F
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):910-5. PubMed ID: 23888997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone target organ protection by eplerenone.
    Rudolph AE; Rocha R; McMahon EG
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):229-38. PubMed ID: 15134822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone blockade in patients with systolic left ventricular dysfunction.
    Pitt B
    Circulation; 2003 Oct; 108(15):1790-4. PubMed ID: 14557343
    [No Abstract]   [Full Text] [Related]  

  • 6. Why are mineralocorticoid receptor antagonists cardioprotective?
    Chai W; Danser AH
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):153-62. PubMed ID: 17075718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular disease.
    Pitt B; Stier CT; Rajagopalan S
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):164-8. PubMed ID: 14608520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocyte mineralocorticoid receptor function post myocardial infarction.
    Fraccarollo D; Bauersachs J
    Trends Cardiovasc Med; 2011 Feb; 21(2):42-7. PubMed ID: 22578239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone and end-organ damage.
    Marney AM; Brown NJ
    Clin Sci (Lond); 2007 Sep; 113(6):267-78. PubMed ID: 17683282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone and mineralocorticoid receptors in the cardiovascular system.
    Funder JW
    Prog Cardiovasc Dis; 2010; 52(5):393-400. PubMed ID: 20226957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RALES, EPHESUS and redox.
    Funder JW
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):121-5. PubMed ID: 15860254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone, oxidative stress, and NF-κB activation in hypertension-related cardiovascular and renal diseases.
    Queisser N; Schupp N
    Free Radic Biol Med; 2012 Jul; 53(2):314-27. PubMed ID: 22609249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptor activation and cardiac fibrosis.
    Young MJ; Lam EY; Rickard AJ
    Clin Sci (Lond); 2007 Jul; 112(9):467-75. PubMed ID: 17391102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid receptors in the metabolic syndrome.
    Zennaro MC; Caprio M; Fève B
    Trends Endocrinol Metab; 2009 Nov; 20(9):444-51. PubMed ID: 19800255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aldosterone as an endogenous cardiovascular toxin and the options for its therapeutic management].
    Horký K
    Vnitr Lek; 2011 Dec; 57(12):1012-6. PubMed ID: 22277034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mineralocorticoid receptor: an update].
    Nagase M
    Nihon Rinsho; 2012 Sep; 70(9):1504-9. PubMed ID: 23012795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis.
    Young MJ; Rickard AJ
    Mol Cell Endocrinol; 2012 Mar; 350(2):248-55. PubMed ID: 21930186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of heart failure following myocardial infarction.
    Struthers AD
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone receptor antagonists.
    Azizi M
    Ann Endocrinol (Paris); 2021 Jun; 82(3-4):179-181. PubMed ID: 32473789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.